UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
As previously disclosed, on March 16, 2018, the Organovo Holdings, Inc. (the “Company”) entered into a Sales Agreement with H.C. Wainwright & Co., LLC and JonesTrading Institutional Services LLC (each an “Agent” and together, the “Agents”), pursuant to which the Company may offer and sell, from time to time through the Agents, shares of its common stock, par value $0.001 per share (“Common Stock”), in “at the market” sales transactions having an aggregate offering price of up to $50,000,000 (the “ATM Offering”).
Between February 1, 2024 and April 19, 2024, the Company issued an aggregate of 1,349,778 shares of Common Stock pursuant to the ATM Offering for total gross proceeds of approximately $1.8 million.
As of April 19, 2024, and after giving effect to the transactions described above, among others, the Company has 11,391,102 shares of Common Stock issued and outstanding.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Number |
|
Description |
|
|
|
104 |
|
Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). |
|
|
|
* * *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
Date: |
April 23, 2024 |
By: |
/s/ Keith Murphy |
|
|
|
Name: Keith Murphy |
Document And Entity Information |
Apr. 19, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Apr. 19, 2024 |
| Entity Registrant Name | Organovo Holdings, Inc. |
| Entity Central Index Key | 0001497253 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-35996 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 27-1488943 |
| Entity Address, Address Line One | 11555 Sorrento Valley Rd |
| Entity Address, Address Line Two | Suite 100 |
| Entity Address, City or Town | San Diego |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 92121 |
| City Area Code | (858) |
| Local Phone Number | 224-1000 |
| Entity Information, Former Legal or Registered Name | 11555 Sorrento Valley Road, Suite 100San Diego, CA 92121 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value |
| Trading Symbol | ONVO |
| Security Exchange Name | NASDAQ |